Tavneos Drug Recall in Ireland

A recall of the autoimmune drug Tavneos (Avacopan) has been issued in the Republic of Ireland after European authorities recommended its removal from the market. The drug, used to treat severe autoimmune blood vessel inflammation, was withdrawn from distribution following safety concerns, with about 60 patients previously prescribed the medication. Patients are advised to consult their doctors before discontinuing treatment.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل